CRL · Healthcare
CHARLES RIV LABS INTL INC
Smart-money confidence
· 1 of 3 sources firing
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
51
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
◆ Next steps
Interested in CHARLES RIV LABS INTL INC? Here's what to do with it.
◇
Compare with other stocks
Sort 7,111 stocks by confidence, holders, or Congress signal
◈
Backtest the strategy
See how the model has done historically before you commit real money
✉
Get the weekly digest
One email on Sunday · what changed in the model this week
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$10.8B
Industry
Diagnostics & Research
Sector
Healthcare
Exchange
NYSE
About CHARLES RIV LABS INTL INC
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic…
Who's behind the signal
Every informed buyer we can see on CRL, across all three feeds.
Hedge funds · 9
Point72 (Steve Cohen)
New position
Soros Fund Management (Soros)
New position
Citadel Advisors
Increased +254%
Bridgewater Associates (Dalio)
Increased +11%
Gotham Asset Mgmt (Greenblatt)
Decreased −8%
D.E. Shaw & Co
Decreased −55%
+3 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trade history · 3
Every disclosed buy & sell on record — STOCK Act filings
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-08-25 | Zoe Lofgren · D-CA | House | SOLD | $1,001 - $15,000 |
| 2021-09-30 | Zoe Lofgren · D-CA | House | BOUGHT | $1,001 - $15,000 |
| 2019-06-24 | Donna E. Shalala · D-FL | House | SOLD | $1,001 - $15,000 |
Not a model pick — but on our radar.
CHARLES RIV LABS INTL INC isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
2
New positions
2
Increasing
5
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
% of portfolio
0.1%
Position change
NEW
0.1% of Point72's portfolio
Trust weight: 1.5×
% of portfolio
0.0%
Position change
NEW
0.0% of Soros Fund Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+254%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
+11%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.1×
% of portfolio
0.2%
Position change
−8%
0.2% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−55%
0.1% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−29%
0.1% of Millennium Management's portfolio
Trust weight: 1.2×
% of portfolio
0.0%
Position change
−95%
0.0% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−55%
0.0% of AQR Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to CHARLES RIV LABS INTL INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell CHARLES RIV LABS INTL INC or any security.
Get the Weekly Update
Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime